ARCHIVES

FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

Matrisian, Nelson, to lead review of NCI translational research programs.

September 23, 2005

Congressional Panel Is Investigating FDA Oversight Of Generic Cancer Drugs

August 18, 1995

FDA Warns of Lymphoma Risk Associated With Breast Implants

January 28, 2011

Members of Congress say that won’t work.

September 30, 2005

Radio-Immunotherapy Advances May Rival Those With Drugs

April 16, 1976

In Brief: Columbia’s Marks Said To Be Cancer Panel New Member; Eight VCP Cregs Awarded

April 2, 1976